Caspases and cancer: mechanisms of inactivation and new treatment modalities.
about
S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3Response rate of fibrosarcoma cells to cytotoxic drugs on the expression level correlates to the therapeutic response rate of fibrosarcomas and is mediated by regulation of apoptotic pathwaysApoptotic pathways as a therapeutic target for colorectal cancer treatmentHealth and cellular impacts of air pollutants: from cytoprotection to cytotoxicityMolecular integrative clustering of Asian gastric cell lines revealed two distinct chemosensitivity clustersSelective Pro-Apoptotic Activity of Novel 3,3'-(Aryl/Alkyl-Methylene)Bis(2-Hydroxynaphthalene-1,4-Dione) Derivatives on Human Cancer Cells via the Induction Reactive Oxygen SpeciesThe loss of CASP4 expression is associated with poor prognosis in esophageal squamous cell carcinomahnRNP L regulates the tumorigenic capacity of lung cancer xenografts in mice via caspase-9 pre-mRNA processingLiving or dying by RNA processing: caspase expression in NSCLC.Caspase functions in cell death and disease.Alternative splicing of caspase 9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a.Apoptosis in cancer: from pathogenesis to treatment.Small Molecule Active Site Directed Tools for Studying Human CaspasesMechanism of Action of Two Flavone Isomers Targeting Cancer Cells with Varying Cell Differentiation Status.CpG island methylation of TMS1/ASC and CASP8 genes in cervical cancer.The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells.Remote effect of kidney ischemia-reperfusion injury on pancreas: role of oxidative stress and mitochondrial apoptosisBozepinib, a novel small antitumor agent, induces PKR-mediated apoptosis and synergizes with IFNα triggering apoptosis, autophagy and senescence.Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development.Caspase-independent mitochondrial cell death results from loss of respiration, not cytotoxic protein release.Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development.The prognostic value of the apoptosis pathway in colorectal cancer: a review of the literature on biomarkers identified by immunohistochemistry.Targeting the VEGF and PDGF signaling pathway in glioblastoma treatment.AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumour cells.Tetrazolium violet induced apoptosis and cell cycle arrest in human lung cancer a549 cellsRemoval from adherent culture contributes to apoptosis in human bone marrow mesenchymal stem cells.Apoptosis in health and disease and modulation of apoptosis for therapy: An overviewAn executioner caspase regulates autophagy.Apigenin Induces Apoptosis through a Mitochondria/Caspase-Pathway in Human Breast Cancer MDA-MB-453 Cells.Panduratin A Inhibits Cell Proliferation by Inducing G0/G1 Phase Cell Cycle Arrest and Induces Apoptosis in Breast Cancer Cells.Downregulation of Frizzled-7 induces the apoptosis of hepatocellular carcinoma cells through inhibition of NF-κB.
P2860
Q24321217-1D302925-7012-4F49-8110-F30CECB70FECQ24810525-39D13893-AE4D-4ACD-B916-6392E8934043Q26738304-76CE4E5E-6860-4D1D-AFE0-50B8BF7A992EQ28383581-6706C94B-2F7B-4D28-920B-4E445A5DF802Q28544116-6C3C08D8-3C4B-46F2-B7D5-519635E1F7F3Q28552362-DDB550F1-4BCB-49F9-8CC6-545E7B049EDCQ33599378-13A251CA-423B-41CF-BACD-AB1ECF2F0731Q34245430-C89D2536-9518-469B-81D1-0BDD71F1111FQ34245513-74CB0C26-2594-4E29-B5C2-11934A7E89FBQ34336335-EA4D72C8-2EDC-47A8-9562-17E28263CA64Q34685905-BE62143E-BB8E-4287-B84D-8E3B0D17AC03Q35397889-9097D138-A2A2-4480-9B71-3CEB404D532CQ35836079-63ADDFC3-0DEC-4AB2-A4D3-9CD53D4D06CEQ35852395-DB93F15E-EFF6-468F-9FAC-E2DB3E73CDA5Q35959023-669D04DD-A793-4F26-A3B9-711257C0DFC5Q36265434-BCB7A735-9D97-460B-8644-ECB867231ABFQ36845257-C4553B0A-4C1B-4FE5-B6C1-6421EE3A9CC7Q37272761-BB27F705-CD55-4A60-8B17-FFD88A9256AAQ37295309-17027F5A-D60C-4AE3-ABBB-7B711C5FF06FQ37448270-57E8D6B9-3A8C-4CFD-845B-6084AC0F8F47Q37947984-7CDC32B2-2A81-4980-A81F-F77B82EDCFCEQ38157864-AB4427D8-C367-438F-81BC-0AA55FBAC8A4Q38838030-96CB6ED2-BC1A-4470-B1DF-0FDD0E29E9DDQ39733339-287C8FC8-BB70-46F7-B970-891DAC1AF82EQ41762581-B8C6C3B5-4C68-4D59-A2BE-0DA5BCE82151Q41993525-52F293E8-63DD-44A1-A5E2-A95B20D09CCAQ42742476-71072CCB-DB62-4BAB-8145-9E47A6945359Q42802552-A7E3AF87-6425-41DB-ADF4-9BF91EF21B14Q43138260-9D4C20DB-3D5A-4366-8C36-50BDFE2095D5Q47208980-8709B2D6-68AA-43DD-9940-2BBEB351321AQ55380301-5B263916-C5B0-42E8-8F9E-78BF302DC8B8
P2860
Caspases and cancer: mechanisms of inactivation and new treatment modalities.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Caspases and cancer: mechanisms of inactivation and new treatment modalities.
@ast
Caspases and cancer: mechanisms of inactivation and new treatment modalities.
@en
type
label
Caspases and cancer: mechanisms of inactivation and new treatment modalities.
@ast
Caspases and cancer: mechanisms of inactivation and new treatment modalities.
@en
prefLabel
Caspases and cancer: mechanisms of inactivation and new treatment modalities.
@ast
Caspases and cancer: mechanisms of inactivation and new treatment modalities.
@en
P2093
P1476
Caspases and cancer: mechanisms of inactivation and new treatment modalities.
@en
P2093
Aleksei Philchenkov
Michael Zavelevich
Tadeusz J Kroczak
P50
P577
2004-06-01T00:00:00Z